AUPH vs CMA
Aurinia Pharmaceuticals Inc (AUPH) versus CMA (CMA) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
CMA (CMA) common stock.
Latest reported AUPH revenue for 2026-06-30 was $160.9M. Net income was $71.8M. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
CMA does not have a complete income-statement cache yet.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Not investment advice. Open the AUPH and CMA stock pages for the full models.
Not investment advice.